Real-world evidence of mortality and survival rates in 256 individuals with APDS
Jennifer Hanson, View ORCID ProfilePenelope E. Bonnen
doi: https://doi.org/10.1101/2022.12.05.22283110
Jennifer Hanson
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
Penelope E. Bonnen
1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA
Article usage
Posted December 06, 2022.
Real-world evidence of mortality and survival rates in 256 individuals with APDS
Jennifer Hanson, Penelope E. Bonnen
medRxiv 2022.12.05.22283110; doi: https://doi.org/10.1101/2022.12.05.22283110
Subject Area
Subject Areas
- Addiction Medicine (396)
- Allergy and Immunology (708)
- Anesthesia (199)
- Cardiovascular Medicine (2909)
- Dermatology (249)
- Emergency Medicine (437)
- Epidemiology (12682)
- Forensic Medicine (10)
- Gastroenterology (824)
- Genetic and Genomic Medicine (4538)
- Geriatric Medicine (413)
- Health Economics (723)
- Health Informatics (2898)
- Health Policy (1066)
- Hematology (383)
- HIV/AIDS (919)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4304)
- Nursing (233)
- Nutrition (633)
- Oncology (2251)
- Ophthalmology (640)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (276)
- Palliative Medicine (83)
- Pathology (496)
- Pediatrics (1192)
- Primary Care Research (492)
- Public and Global Health (6888)
- Radiology and Imaging (1517)
- Respiratory Medicine (912)
- Rheumatology (433)
- Sports Medicine (381)
- Surgery (482)
- Toxicology (60)
- Transplantation (208)
- Urology (178)